ABACAVIR SANDOZ 300mg film-coated tablets medication leaflet

J05AF06 • abacavir • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Abacavir is a medication used to treat HIV/AIDS.
Similar to other nucleoside analog reverse-transcriptase inhibitors (NRTIs), abacavir is used together with other HIV medications, and is not recommended by itself.
It is taken by mouth as a tablet or solution and may be used in children over the age of three months.

Abacavir was patented in 1988, and approved for use in the United States in 1998.
It is on the World Health Organization's List of Essential Medicines.
It is available as a generic medication.
Abacavir is used together with other HIV medications, such as abacavir/lamivudine/zidovudine, abacavir/dolutegravir/lamivudine, and abacavir/lamivudine.
The combination abacavir/lamivudine is an essential medicine.

Abacavir is a nucleoside reverse transcriptase inhibitor that inhibits viral replication.
It is a guanosine analogue that is phosphorylated to carbovir triphosphate (CBV-TP).
CBV-TP competes with the viral molecules and is incorporated into the viral DNA.
Once CBV-TP is integrated into the viral DNA, transcription and HIV reverse transcriptase is inhibited.